Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cheapest Mounjaro pen you can find in the UK private market is not necessarily the best-value one. Private prices for tirzepatide vary by dose and provider, and since Eli Lilly raised UK list prices in September 2025, monthly costs across providers have ranged roughly from £149 to £375 depending on the dose — figures widely reported at the time of the change. What that headline number actually covers, though, differs considerably. Mounjaro is a prescription-only medicine, which means a prescriber has to assess your suitability before any treatment can be dispensed; the price has to include that process somehow, whether it is visible or buried in the total.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is available in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each pen contains four weekly doses, and treatment starts at 2.5mg before being titrated upward by the prescriber, typically in four-week steps. That means the pen you begin on is almost certainly not the pen you will be on in six months' time, and the price changes accordingly.
If you are comparing costs at a particular dose (say, 5mg or 7.5mg) that monthly figure is a more meaningful number than a generic entry-level price. The wider picture of how pricing shifts across the dose ladder is covered in detail on our Mounjaro pricing page.
One practical check you can do in under a minute: look up any online pharmacy on the GPhC register before you hand over payment details. Registered pharmacies will appear immediately. If they do not appear, that is reason enough to stop.
A low advertised price for a Mounjaro pen can look appealing, but the full cost of treatment (legally and practically) involves more than the medicine itself. Clinical consultations, prescriptions and follow-up support each cost something to provide. Some providers list them separately; others fold them in. Neither approach is wrong, but the total matters.
Common extras that appear only at checkout, or only when you need them, include: initial consultation fees, prescription charges, delivery costs, and any clinical review fee before a dose increase. If a prescriber is not reviewing your progress before each repeat, that is a clinical gap rather than a saving. NHS England's guidance on weight-management injections sets out clearly that ongoing clinical oversight (not just an initial sign-off) is part of safe prescribing.
For context on what responsible private treatment should look like more broadly, our weight-loss treatment overview runs through what to expect at each stage.
We do not run discount codes, promotional pricing or subscription tie-ins. We are not trying to win a price comparison. One transparent figure covers the consultation, the prescription, the medicine, and free next-working-day delivery via DPD in plain packaging. There are no extras waiting on the other side of the checkout.
That single price is not the lowest you will find. We set it that way deliberately, because the service it funds (identity verification, live weight checks, same-day review by a real prescriber, seven-day aftercare and a clinical re-review before every repeat) has a genuine cost. You can read about the clinical team behind that process on our clinical lead's profile page, or find out more about how the service runs on our about us page.
Current treatment pricing is shown on our consultation and treatment page, alongside the eligibility criteria our prescribers assess at the consultation stage.
For a pair of trainers, cheapest might be fine. For a prescription-only injectable medicine, the question that actually protects you is whether the supply chain is legitimate and the clinical oversight is real.
The MHRA has warned publicly and repeatedly about counterfeit weight-loss pens sold online, including through social media. Fake pens seized by UK enforcement have in some cases contained insulin rather than tirzepatide, a potentially dangerous substitution. If you want to understand what happens to Mounjaro price across the dose ladder and why it shifts the way it does, that context makes the risks of bargain-hunting clearer. A small saving on a pen from an unverified seller is not a discount; it is an unknown risk. You can report suspect sellers via the MHRA's Yellow Card scheme, which also covers suspected side effects from genuine medicines.
Legitimate treatment means a prescription written by a clinician who has actually assessed you, medicine dispensed by a pharmacy you can verify on the register, and supply that traces back to the licensed UK chain. If you are weighing up the options at a specific dose (for example at 10mg) the right comparison is not just price per pen, but what each option includes around it, and our guide to finding a cheap Mounjaro pen that is also safe and legitimate explains exactly what to look for. Our FAQs cover common questions about how the process works.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.